
    
      To compare the pharmacokinetic (PK) profiles of methotrexate (MTX) following a subcutaneous
      (SC) injection of MTX using the Vibex device to that obtained after an SC injection of MTX
      without using the device and to that obtained after an intramuscular (IM) injection of MTX in
      adult subjects with rheumatoid arthritis (RA).
    
  